Mesenchymal stem cells - From biology to clinical application

被引：0
作者：
Meisel, R. [1 ]
Kuci, S. [2 ]
Mueller, I. [3 ]
机构：
[1] Univ Klinikum Dusseldorf, Klin Kinder Onkol Hematol & Klin Immunol, Zentrum Kinder & Jugendmed, D-40225 Dusseldorf, Germany
[2] Klinikum Johann Wolfgang Goethe Univ, Zentrum Kinder & Jugendmed, Klin Hematol Onkol & Hamostaseol 3, Frankfurt, Germany
[3] Univ Klin Kinder & Jugendmed Tubingen, Abt Allgemeine Padiatrie, Tubingen, Germany
来源：
MONATSSCHRIFT KINDERHEILKUNDE | 2010年 / 158卷 / 03期
关键词：
Mesenchymal stem cells; Immunosuppression; Endogenous tissue repair; Graft-versus-host disease; Osteonecrosis; THERAPY POSITION STATEMENT; VERSUS-HOST-DISEASE; STROMAL CELLS; INTERNATIONAL-SOCIETY; MYOCARDIAL-INFARCTION; PEDIATRIC-PATIENTS; IN-VITRO; TRANSPLANTATION; BONE; MICE;
D O I：
10.1007/s00112-009-2141-4
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Mesenchymal stem cells exhibit multilineage differentiation potential and support endogenous tissue repair and haematopoiesis. In addition, they have been shown to inhibit proliferation and effector functions of various immune cells. Based on these properties, mesenchymal stem cells are currently under intensive preclinical and clinical investigation in different therapeutic applications. First promising data in children have been reported from the use of mesenchymal stem cells in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation and in the treatment of avascular osteonecrosis after cancer chemotherapy. If mesenchymal stem cells prove to be clinically efficacious in prospective clinical trials with regard to immunosuppression and support of endogenous tissue repair, they will represent a promising novel treatment option for various fields of application, including (but not limited to) paediatric autoimmune diseases, thus reaching far beyond the reported clinical experience in haemato-oncology.
引用
收藏
页码：240 / 245
页数：6
相关论文
共 27 条
[1]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[2]   Osteonecrosis:: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) -: Experiences from trial ALL-BFM 95 [J].
Bürger, B ;
Beier, R ;
Zimmermann, M ;
Beck, JD ;
Reiter, A ;
Schrappe, M .
PEDIATRIC BLOOD & CANCER, 2005, 44 (03) :220-225
[3]   Osteoblastic cells regulate the haematopoietic stem cell niche [J].
Calvi, LM ;
Adams, GB ;
Weibrecht, KW ;
Weber, JM ;
Olson, DP ;
Knight, MC ;
Martin, RP ;
Schipani, E ;
Divieti, P ;
Bringhurst, FR ;
Milner, LA ;
Kronenberg, HM ;
Scadden, DT .
NATURE, 2003, 425 (6960) :841-846
[4]   Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L [J].
Christopeit, M. ;
Schendel, M. ;
Foell, J. ;
Mueller, L. P. ;
Keysser, G. ;
Behre, G. .
LEUKEMIA, 2008, 22 (05) :1062-1064
[5]   Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice [J].
Deng, WN ;
Han, Q ;
Liao, LM ;
You, SG ;
Deng, HY ;
Zhao, RCH .
DNA AND CELL BIOLOGY, 2005, 24 (07) :458-463
[6]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[7]  
FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
[8]   Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis impertecta mice [J].
Guillot, Pascale V. ;
Abass, Oyebode ;
Bassett, J. H. Duncan ;
Shefelbine, Sandra J. ;
Bou-Gharios, George ;
Chan, Jerry ;
Kurata, Hitoshi ;
Williams, Graham R. ;
Polak, Julia ;
Fisk, Nicholas M. .
BLOOD, 2008, 111 (03) :1717-1725
[9]   Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction [J].
Guo, Jun ;
Lin, Guo-sheng ;
Bao, Cui-yu ;
Hu, Zhi-min ;
Hu, Ming-yan .
INFLAMMATION, 2007, 30 (3-4) :97-104
[10]   A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction [J].
Hare, Joshua M. ;
Traverse, Jay H. ;
Henry, Timothy D. ;
Dib, Nabil ;
Strumpf, Robert K. ;
Schulman, Steven P. ;
Gerstenblith, Gary ;
DeMaria, Anthony N. ;
Denktas, Ali E. ;
Gammon, Roger S. ;
Hermiller, James B., Jr. ;
Reisman, Mark A. ;
Schaer, Gary L. ;
Sherman, Warren .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (24) :2277-2286
123